News

America’s Looming Health Crisis: The Chronic Disease Epidemic

As chronic disease becomes the norm, Cedrick Wellness Resources is calling for a nutrition-first approach to win the war on…

8 months ago

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

TORONTO, ON / ACCESSWIRE / July 26, 2023 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage…

8 months ago

Delota Corp. and Parkdale Community Food Bank Form CSR Partnership

Vaughan, Ontario--(Newsfile Corp. - July 26, 2023) - Delota Corp. (CSE: LOTA) ("Delota" or the "Company") spearheads the smoke-free revolution…

8 months ago

CPSI to Webcast Its Second Quarter 2023 Conference Call

MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that it will release its financial results for the…

8 months ago

Wolters Kluwer awarded highest client satisfaction award from Black Book Research

Sentri7 and Simplifi+ solutions recognized as top-performing hospital techWALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that the Sentri7® clinical surveillance…

8 months ago

Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology

REDWOOD CITY, CA / ACCESSWIRE / July 26, 2023 / The integration of AI technology in healthcare has revolutionized the…

8 months ago

CBD of Denver Files to Change Name and Symbol Change to Berliner Innovation and Provide Additional Corporate Updates

Denver, Colorado--(Newsfile Corp. - July 26, 2023) - CBD of Denver (OTC Pink: CBDD) today announced that it has filed…

8 months ago

Philips Named to the Forbes Best Employers for Women 2023 List

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company earned…

8 months ago

Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

8 months ago

Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Canalevia®-CA1 is currently FDA conditionally approved for treatment of CID in dogs and is the first and only treatment for…

8 months ago